Natalizumab as a Disease-Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy - A Report of Three Cases

Publisher： Karger

E-ISSN： 1421-9913|73|5-6|294-302

ISSN： 0014-3022

Source： European Neurology, Vol.73, Iss.5-6, 2015-04, pp. : 294-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mixed connective tissue disease associated with chronic inflammatory demyelinating polyneuropathy: CASE REPORT

By Luostarinen Liisa   Himanen Sari-Leena   Pirttilä Tuula   Molnar Gabor  

Scandinavian Journal of Rheumatology, Vol. 28, Iss. 5, 1999-09 ,pp. : 328-330

Informa Healthcare

Access to resources Recommend Favorite

Acute Myocardial Infarction following Intravenous Immunoglobulin Therapy for Chronic Inflammatory Demyelinating Polyneuropathy in Association with a Monoclonal Immunoglobulin G Paraprotein

By  

European Neurology, Vol. 51, Iss. 1, 2004-01 ,pp. : 51-

Karger

Access to resources Recommend Favorite

Bilateral Hypoglossal Nerve Involvement in Chronic Inflammatory Demyelinating Polyneuropathy

By  

European Neurology, Vol. 51, Iss. 1, 2004-01 ,pp. : 45-46

Karger

Access to resources Recommend Favorite

Optimization of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy Evaluated by Grip Strength Measurement

By  

European Neurology, Vol. 70, Iss. 1-2, 2013-06 ,pp. : 65-69

Karger

Access to resources Recommend Favorite

Incidence and Natural History of Idiopathic Chronic Inflammatory Demyelinating Polyneuropathy: A Population-Based Study in Iceland

By  

European Neurology, Vol. 75, Iss. 5-6, 2016-05 ,pp. : 263-268

Karger

Access to resources Recommend Favorite